KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Taxes: 2021-2023

Historic Change in Taxes for Moderna (MRNA) over the last 3 years, with Dec 2023 value amounting to $15.0 million.

  • Moderna's Change in Taxes fell 122.22% to -$2.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$51.0 million, marking a year-over-year decrease of 410.00%. This contributed to the annual value of $15.0 million for FY2023, which is 101.81% up from last year.
  • Moderna's Change in Taxes amounted to $15.0 million in FY2023, which was up 101.81% from -$828.0 million recorded in FY2022.
  • Moderna's 5-year Change in Taxes high stood at $876.0 million for FY2021, and its period low was -$828.0 million during FY2022.
  • In the last 3 years, Moderna's Change in Taxes had a median value of $15.0 million in 2023 and averaged $21.0 million.
  • Its Change in Taxes has fluctuated over the past 5 years, first slumped by 194.52% in 2022, then skyrocketed by 101.81% in 2023.
  • Moderna's Change in Taxes (Yearly) stood at $876.0 million in 2021, then slumped by 194.52% to -$828.0 million in 2022, then surged by 101.81% to $15.0 million in 2023.